chemotherapy
Showing 9976 - 10000 of >10,000
Other Cancer, Gastrointestinal Cancer, Thoracic Cancer Trial in United States (eSyM App Usage, SASS Questionnaire)
Recruiting
- Other Cancer
- +3 more
- eSyM App Usage
- SASS Questionnaire
-
Portland, Maine
- +5 more
Nov 2, 2021
Acute Myelocytic Leukemia, Myelodysplastic Syndrome Trial in Germany (Azacitidine)
Completed
- Acute Myelocytic Leukemia
- Myelodysplastic Syndrome
-
Berlin, Germany
- +10 more
Nov 12, 2021
Age on Sperm Recovery of Microdissection Testicular Sperm
Completed
- Non-obstructive Azoospermia
-
Beijing, Beijing, ChinaPeking University Third Hospital
Jul 21, 2023
Solid Tumor Trial in Shanghai (GT201)
Recruiting
- Solid Tumor
- GT201
-
Shanghai, Shanghai, ChinaRenji Hospital Affiliated to Shanghai Jiaotong University School
Feb 1, 2023
Monitoring of Chronic Conditions in Breast Cancer
Recruiting
- Breast Cancer
- Chronic Fatigue Syndrome
-
Stavanger, NorwayHelse Stavanger HF
Oct 19, 2022
Suture Size, Incisional Hernia Trial in Muscat (closure of the abdominal fascia)
Enrolling by invitation
- Suture Size, Incisional Hernia
- closure of the abdominal fascia
-
Muscat, OmanRaya Al Shaaibi
Aug 1, 2022
Autonomic Nervous System in Patients Undergoing Esophagectomy
Not yet recruiting
- Esophageal Cancer
- Holter ECG
- +2 more
-
Saint-Étienne, FranceCentre Hospitalier Universitaire de Saint-Etienne
Dec 1, 2021
Prostate Cancer, Bone Metastases Trial in Brescia (Zoledronic Acid, Enzalutamide)
Recruiting
- Prostate Cancer
- Bone Metastases
- Zoledronic Acid
- Enzalutamide
-
Brescia, ItalyAzienda Ospedaliera Spedali Civili di Brescia
Mar 4, 2022
Bladder Tumor, Magnetic Resonance Imaging Trial in Guangzhou (MRI)
Recruiting
- Bladder Tumor
- Magnetic Resonance Imaging
- MRI
-
Guangzhou, Guang Dong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Sep 4, 2023
Lung Tumors, NSCLC, Carcinoma, Small Cell Trial in Iowa City, Baltimore (Rhenium (Re 188 P2045, BAY86-5284))
Unknown status
- Lung Neoplasms
- +3 more
- Rhenium (Re 188 P2045, BAY86-5284)
-
Iowa City, Iowa
- +1 more
Jan 9, 2019
Breast Cancer Trial in Baltimore (Tamoxifen Citrate, Letrozole, Exemestane)
Recruiting
- Breast Cancer
- Tamoxifen Citrate
- +4 more
-
Baltimore, MarylandJohns Hopkins Bayview Hospital
Nov 30, 2021
Spinal Induced Hypotension Trial in Cairo (Ondansetron 4 MG, Ondansetron 8mg, EPHEDrine 10 Mg/mL-NaCl 0.9% Intravenous Solution)
Completed
- Spinal Induced Hypotension
- Ondansetron 4 MG
- +3 more
-
Cairo, EgyptAin Shams University Hospitals
Sep 7, 2022
Organoids, Epithelial Ovarian Cancer Trial in Rome (Tumor biopsy)
Recruiting
- Organoids
- Epithelial Ovarian Cancer
- Tumor biopsy
-
Rome, ItalyFondazione Policlinico Universitario "A. Gemelli" IRCCS
Sep 14, 2020
Hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in United States (AB-205, Placebo)
Recruiting
- Hodgkin Lymphoma
- Non Hodgkin Lymphoma
- AB-205
- Placebo
-
Duarte, California
- +20 more
Aug 2, 2022
Metastatic Pancreatic Cancer Trial in Dallas (SGT-53, nab-paclitaxel, Gemcitabine)
Recruiting
- Metastatic Pancreatic Cancer
- SGT-53
- +2 more
-
Dallas, TexasMary Crowley Cancer Research Center
Feb 7, 2022
Therapeutic Care in Metastatic Breast Cancer From 2008
Recruiting
- Metastatic Breast Cancer
-
Angers, France
- +19 more
Jun 30, 2022
Neuroblastoma, Pheochromocytoma Trial in New Hyde Park (131-I-meta-iodobenzylguanidine)
Available
- Neuroblastoma
- Pheochromocytoma
-
New Hyde Park, New YorkCohen Children's Medical Center
Apr 4, 2022
Thyroglobulin and Galectin-3 for Prognosis and Follow-up in
Recruiting
- Thyroid Cancer
- +2 more
-
Taipei, TaiwanChih-Yuan Wang, M.D
Oct 16, 2022
Quality of Life After Conservative Oncoplastic Surgery in Breast
Recruiting
- Breast Cancer
- Study and recording of post-surgical clinical and pathological data of patients diagnosed with breast cancer undergoing unilateral or bilateral conservative oncoplastic surgery.
- +2 more
-
Roma, ItalyPaolo Orsaria, MD. PhD; [porsaria]
Apr 22, 2023
Sarcoma Trial in Shanghai (Apatinib monotherapy)
Recruiting
- Sarcoma
- Apatinib monotherapy
-
Shanghai, Shanghai, ChinaRuijin Hospital Shanghai Jiao Tong University School of Medicine
May 18, 2022
Esophageal Squamous Cell Carcinoma Trial in Shanghai (Pembrolizumab Injection)
Recruiting
- Esophageal Squamous Cell Carcinoma
- Pembrolizumab Injection
-
Shanghai, Shanghai, China
- +1 more
Aug 29, 2021
Resected Pancreatic and Ampullary Adenocarcinoma at Favorable
Enrolling by invitation
- Resectable Pancreatic Adenocarcinoma
-
Milan, ItalyNational Cancer Institute of Milan
Mar 3, 2023
Lung Cancer, Non Small Cell Lung Cancer Trial in Ankara (Low Volume High Intensity Exercise Training, Aerobic Exercise Training)
Recruiting
- Lung Cancer
- Non Small Cell Lung Cancer
- Low Volume High Intensity Exercise Training
- Aerobic Exercise Training
-
Ankara, Sıhhiye, TurkeyAnkara University
Apr 27, 2023
HER2 Positive Advanced Solid Tumors Trial (HypoSti.CAR-HER2 T cells, Albumin-bound paclitaxel, Cyclophosphamide)
Not yet recruiting
- HER2 Positive Advanced Solid Tumors
- HypoSti.CAR-HER2 T cells
- +2 more
- (no location specified)
Jan 12, 2023
Breast Cancer, Tumor Metastasis Trial in Houston (Trastuzumab, RAD001)
Completed
- Breast Cancer
- Neoplasm Metastasis
-
Houston, TexasUT MD Anderson Cancer Center
Sep 30, 2022